KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Revenue: 2009-2025

Historic Revenue for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $850.7 million.

  • Exact Sciences' Revenue rose 20.05% to $850.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 14.47%. This contributed to the annual value of $2.8 billion for FY2024, which is 10.37% up from last year.
  • Per Exact Sciences' latest filing, its Revenue stood at $850.7 million for Q3 2025, which was up 4.89% from $811.1 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Revenue registered a high of $850.7 million during Q3 2025, and its lowest value of $402.1 million during Q1 2021.
  • Its 3-year average for Revenue is $693.4 million, with a median of $699.3 million in 2024.
  • Data for Exact Sciences' Revenue shows a peak YoY skyrocketed of 61.72% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Exact Sciences' Revenue stood at $473.8 million in 2021, then grew by 16.71% to $553.0 million in 2022, then increased by 16.98% to $646.9 million in 2023, then rose by 10.29% to $713.4 million in 2024, then rose by 20.05% to $850.7 million in 2025.
  • Its Revenue stands at $850.7 million for Q3 2025, versus $811.1 million for Q2 2025 and $706.8 million for Q1 2025.